The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis

[11] Ding ZP(2013)Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer Ann Thorac Surg 96 1163-3231

[12] Luo QQ(2018)Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study J Thorac Dis 10 3225-1974

[13] Liang W(2018)Survival patterns for patients with resected N2 non-small cell lung cancer and postoperative radiotherapy: a prognostic scoring model and heat map approach J Thorac Oncol 13 1968-4731

[14] He J(2011)Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer Cancer 117 4724-7259

[15] Shen Y(2004)X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252-657

[16] Krantz SB(2013)Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes Clin Lung Cancer 14 651-260

[17] Lutfi W(2003)Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer J Surg Oncol 82 256-e52

[18] Kuchta K(2014)Demonstration of the skip metastasis pathway for N2 non-small cell lung cancer J Thorac Cardiovasc Surg 147 e50-50

[19] Pignon JP(2014)Determination of sentinel lymph node by Tc(99m) in small-cell lung cancer Tuberk Toraks 62 45-144

[20] Tribodet H(2011)Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer J Thorac Cardiovasc Surg 141 141-233

[11] Ding ZP(2013)Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer Ann Thorac Surg 96 1163-3231

[12] Luo QQ(2018)Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study J Thorac Dis 10 3225-1974

[13] Liang W(2018)Survival patterns for patients with resected N2 non-small cell lung cancer and postoperative radiotherapy: a prognostic scoring model and heat map approach J Thorac Oncol 13 1968-4731

[14] He J(2011)Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer Cancer 117 4724-7259

[15] Shen Y(2004)X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252-657

[16] Krantz SB(2013)Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes Clin Lung Cancer 14 651-260

[17] Lutfi W(2003)Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer J Surg Oncol 82 256-e52

[18] Kuchta K(2014)Demonstration of the skip metastasis pathway for N2 non-small cell lung cancer J Thorac Cardiovasc Surg 147 e50-50

[19] Pignon JP(2014)Determination of sentinel lymph node by Tc(99m) in small-cell lung cancer Tuberk Toraks 62 45-144

[20] Tribodet H(2011)Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer J Thorac Cardiovasc Surg 141 141-233